Frequent genomic alterations and better prognosis among young patients with non-small-cell lung cancer aged 40 years or younger.
X PanT LvF ZhangH FanH LiuYong SongPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2018)
Young patients are associated with an increased likelihood of gene mutations and can receive a better prognosis when patients harboring gene mutations are treated with EGFR-TKIs or ALK inhibitors.